Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youlan Rao

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Annals of the American Thoracic Society|July 6, 2023
A Novel Approach to Clinical Change Endpoints: A Win Ratio Analysis of the INCREASE TrialSteven D Nathan, Boris Medarov, Lawrence Ho, et al.
International Journal of Cardiology|April 17, 2017
What's in a side effect? The association between pulmonary vasodilator adverse drug events and clinical outcomes in patients with pulmonary arterial hypertensionPeter J Leary, Suhyun Kang, Todd M Kolb, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 18, 2022
Contemporary risk scores predict clinical worsening in pulmonary arterial hypertension - An analysis of FREEDOM-EVRaymond L Benza, Mardi Gomberg-Maitland, Harrison W Farber, et al.
Clinical Rheumatology|December 21, 2019
Vascular biomarkers and digital ulcerations in systemic sclerosis: results from a randomized controlled trial of oral treprostinil (DISTOL-1)Christopher A Mecoli, Jamie Perin, Jennifer E Van Eyk, et al.
Molecular Cancer Therapeutics|May 22, 2012
MLN0905, a small-molecule plk1 inhibitor, induces antitumor responses in human models of diffuse large B-cell lymphomaJudy Quiju Shi, Kerri Lasky, Vaishali Shinde, et al.
The New England Journal of Medicine|May 18, 2026
Phase 3 Trials of Inhaled Treprostinil for Idiopathic Pulmonary FibrosisSteven D Nathan, Peter Smith, Chunqin Deng, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Annals of the American Thoracic Society|July 6, 2023
A Novel Approach to Clinical Change Endpoints: A Win Ratio Analysis of the INCREASE TrialSteven D Nathan, Boris Medarov, Lawrence Ho, et al.
International Journal of Cardiology|April 17, 2017
What's in a side effect? The association between pulmonary vasodilator adverse drug events and clinical outcomes in patients with pulmonary arterial hypertensionPeter J Leary, Suhyun Kang, Todd M Kolb, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 18, 2022
Contemporary risk scores predict clinical worsening in pulmonary arterial hypertension - An analysis of FREEDOM-EVRaymond L Benza, Mardi Gomberg-Maitland, Harrison W Farber, et al.
Clinical Rheumatology|December 21, 2019
Vascular biomarkers and digital ulcerations in systemic sclerosis: results from a randomized controlled trial of oral treprostinil (DISTOL-1)Christopher A Mecoli, Jamie Perin, Jennifer E Van Eyk, et al.
Molecular Cancer Therapeutics|May 22, 2012
MLN0905, a small-molecule plk1 inhibitor, induces antitumor responses in human models of diffuse large B-cell lymphomaJudy Quiju Shi, Kerri Lasky, Vaishali Shinde, et al.
The New England Journal of Medicine|May 18, 2026
Phase 3 Trials of Inhaled Treprostinil for Idiopathic Pulmonary FibrosisSteven D Nathan, Peter Smith, Chunqin Deng, et al.
Pageof 3